Christin GALETZKA,Chris RUNDFELDT,Roland RUPP,Peder M. ANDERSEN
申请号：
US15584439
公开号：
US20170231943A1
申请日:
2017.05.02
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg±5% or 400 mg±5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
